Skip to main content
SpringerLink
Log in

αv Integrins mediate adhesion and migration of breast carcinoma cell lines

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

Integrins with the αv subunit are involved in cell adhesion and cellular signaling. Some αv integrins have been associated with tumor progression and dissemination. The objective of this study was to assess the contribution of αv integrins to the adhesive and migratory behavior of cells derived from breast carcinoma (BCA). The expression and function of αv integrins was characterized in three BCA cell lines which exhibit different metastatic potentials. These include MCF-7 cells which metastasize inefficiently, MDA-MB-231 cells, which have a moderate metastatic potential, and MDA-MB-435 cells, which metastasize extensively. Each cell type displays a different repertoire of αv integrins on the cell surface. The complement of αv integrins on each cell type influences their ability to adhere and migrate. The most striking difference among these cell lines was the expression of the αvβ3 3 integrin. The highly metastatic MDA-MB-435 cells express substantial levels of this receptor, whereas MDA-MB-231 and MCF-7 cells do not. The MDA-MB-435 cells showed a greater ability to adhere and to migrate and this functional difference can largely be attributed to the expression of αvβ3 integrin. This characterization is a first step toward determining the role of αv integrins in animal models of BCA metastasis, and lends support to the hypothesis that the αvβ3 integrin can be a contributing factor in metastatic disease. © Rapid Science 1998

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Miller AB and Bulbrook RD, 1986, UICC multi-disciplinary project on breast cancer: the epidemiology, aetiology and prevention of breast cancer. Int J Cancer, 37, 173–7.

    Google Scholar 

  2. Clarke R, Dickson RB and Brunner N, 1990, The process of malignant progression in human breast cancer. Ann Oncol, 1, 401–7.

    Google Scholar 

  3. van de Vijer MJ, 1993, Molecular genetic changes in human breast cancer. In: Vande Woude GF and Klein G, eds. Advances in Cancer Research. San Diego: Academic Press, pp. 25–56.

    Google Scholar 

  4. Hynes RO, 1987, Integrins: a family of cell surface receptors. Cell, 48, 549–50.

    Google Scholar 

  5. Albelda SM and Buck CA, 1990, Integrins and other cell adhesion molecules. FASEB J, 4, 2868–80.

    Google Scholar 

  6. Schwartz MA, 1993, Signaling by integrins: implications for tumorigenesis. Cancer Res, 53, 1503–6.

    Google Scholar 

  7. Schwartz MA, Brown EJ and Fazeli B, 1993, A 50-kDa integrin-associated protein is required for integrin-regulated calcium entry in endothelial cells. J Biol Chem, 268, 19931–4.

    Google Scholar 

  8. Montgomery AM, Reisfeld RA and Cheresh DA, 1994, Integrin αvβ3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc Natl Acad Sci USA, 91, 8856–60.

    Google Scholar 

  9. Hruska KA, Rolnick F, Huskey M, Alvarez U and Cheresh D, 1995, Engagement of the osteoclast integrin αvβ3 by osteopontin stimulates phosphatidylinositol 3-hydroxyl kinase activity. Endocrinology, 136, 2984–92.

    Google Scholar 

  10. Brooks PC, Stromblad S, Sanders LC, et al. 1996, Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell, 85, 683–93.

    Google Scholar 

  11. Zutter MM, Krigman HR and Santoro SA, 1993, Altered integrin expression in adenocarcinoma of the breast. Am J Pathol, 142, 1439–48.

    Google Scholar 

  12. Jones JL, Critchley DR and Walker RA, 1992, Alteration of stromal protein and integrin expression in breast-A marker of premalignant change. J Pathol, 167, 399–406.

    Google Scholar 

  13. Downer CS, Watt FM and Speight PM, 1993, Loss of α6 and β4 integrin subunits coincides with loss of basement membrane components in oral squamous cell carcinomas. J Pathol, 171, 183–90.

    Google Scholar 

  14. Pignatelli M, Cardillo MR, Hanby A and Stamp GWH, 1992, Integrins and their accessory adhesion molecules in mammary carcinomas: Loss of polarization in poorly differentiated tumors. Hum Pathol, 23, 1159–66.

    Google Scholar 

  15. Staatz WD, Rajpara SM, Wayner EA, Carter WG and Santoro SA, 1989, The membrane glycoprotein Ia-IIa (VLA-2) complex mediates the Mg++-dependent adhesion of platelets to collagen. J Cell Biol, 108, 1917–24.

    Google Scholar 

  16. Elices MJ and Hemler ME, 1989, The human integrin VLA-2 is a collagen receptor on some cells and a collagen/laminin receptor on others. Proc Natl Acad Sci USA, 86, 9906–10.

    Google Scholar 

  17. Lee EC, Lotz MM, Steele GD and Mercurio AM, 1992, The integrin α6β4 is a laminin receptor. J Cell Biol, 117, 671–8.

    Google Scholar 

  18. Clezardin P, Frappart L, Clerget M, Pechoux C and Delmas PD, 1993, Expression of thrombospondin (TSP1) and it receptors (CD36 and CD51) in normal, hyperplastic and neoplastic human breast. Cancer Res, 53, 1421–30.

    Google Scholar 

  19. Liapis H, Flath A and Kitazawa S, 1996, Interin αvβ3expression by bone-residing breast cancer metastases. Diag Mol Pathol, 5, 127–35.

    Google Scholar 

  20. Hynes RO, 1992, Integrins: versatility, modulation and signaling in cell adhesion. Cell, 69, 11–25.

    Google Scholar 

  21. Vogel BE, Tarone G, Giancotti FG, Galit J and Ruoslahti E, 1990, A novel fibronectin receptor with an unexpected subunit composition (αvβ1). J Biol Chem, 265, 5934–7.

    Google Scholar 

  22. Bodary SC and McLean JW, 1990, The integrin b1 subunit associates with the vitronectin receptor αvsubunit to form a novel vitronectin receptor in a human embryonic kidney cell line. J Biol Chem, 265, 5938–41.

    Google Scholar 

  23. Smith JW, Vestal DJ, Irwin SV, Burke TA and Cheresh DA, 1990, Purification and functional characterization of integrin αvβ5. J Biol Chem, 265, 11008–13.

    Google Scholar 

  24. Busk M, Pytela R and Sheppard D, 1992, Characterization of the integrin αvβ6 as a fibronectin-binding protein. J Biol Chem, 267, 5790–6.

    Google Scholar 

  25. Panetti T and McKeown-Longo PJ, 1993, The αvβ5 integrin receptor regulates receptor-mediated endocytosis of vitronectin. J Biol Chem, 268, 11492–5.

    Google Scholar 

  26. Leavesley DI, Schwartz MA, Rosenfeld M and Cheresh DA, 1993, Integrin β1-and β3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J Cell Biol, 121, 163–70.

    Google Scholar 

  27. Zhang Z, Morla AO, Vuori K, Bauer JS, Juliano RL and Ruoslahti E, 1993, The αvβ1 integrin functions as a fibronectin receptor but does not support fibronectin matrix assembly and cell migration on fibronectin. J Cell Biol, 122, 235–42.

    Google Scholar 

  28. Albelda SM, Mette SA, Elder DE, et al. 1990, Integrin distribution in malignant melanoma: Association of the β3 subunit with tumor progression. Cancer Res, 50, 6757–64.

    Google Scholar 

  29. Price JE, Polyzos A, Zhang RD and Daniels LM, 1990, Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res, 50, 717–21.

    Google Scholar 

  30. Shafie SM and Liotta LA, 1980, Formation of metastasis by human breast carcinoma cells (MCF-7) in nude mice. Cancer Lett, 11, 81–7.

    Google Scholar 

  31. Kurebayashi J, Mcleskey S, Johnson MD, et al. 1993, Quantitative demonstration of spontaneous metastasis of MCF-7 human breast cancer cells co-transfected with fibroblast growth factor 4 and LacZ. Cancer Res, 53, 2178–87.

    Google Scholar 

  32. Yatohgo T, Izumi M, Kashiwagi H and Hayashi M, 1988, Novel purification of vitronectin from human plasma by heparin affinity chromatography. Cell Struct Funct, 13, 281–92.

    Google Scholar 

  33. Doolittle RF, Schubert D and Schwartz SA, 1967, Amino acid sequence studies of an artiodtactyl fibrinopeptide I. Dromedary camel, mule deer and cape buffalo. Arch Biochem Biophys, 118, 456–521.

    Google Scholar 

  34. Stuiver I and Smith JW, 1995, Characterization of monoclonal antibodies against human integrin vvβ5. Hybridoma, 14, 545–550.

    Google Scholar 

  35. Cheresh DA and Spiro RC, 1987, Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand Factor. J Biol Chem, 262, 17703–11.

    Google Scholar 

  36. Newman PJ, Allen RW, Kahn RA and Kunicki TJ, 1985, Quantitation of membrane glycoprotein IIIa on intact human platelets using the monoclonal antibody, AP-3. Blood, 65, 227–32.

    Google Scholar 

  37. Patent Cooperation Treaty International Application. Title: Platelet Aggregation Inhibitors. PCT NO.WO 96/23771, 1996.

  38. Barbas CF, Languino LR and Smith JW, 1993, High-affinity self-reactive human antibodies by design and selection: targeting the integrin ligand binding site. Proc Natl Acad Sci USA, 90, 10003–7.

    Google Scholar 

  39. Smith JW, Hu D, Satterthwait A, Pinz-Sweeney S and Barbas CF, 1994, Building synthetic antibodies as adhesive ligands for integrins. J Biol Chem, 269, 32788–95.

    Google Scholar 

  40. Pratner CA, Plotkin J, Jaye D and Frazier WA, 1991, The properdin-like type I repeats of human thrombospondin contain a cell attachment site. J Cell Biol, 112, 1031–40.

    Google Scholar 

  41. Bauer JS, Schreiner CL, Giancotti FG, Ruoslahti E and Juliano RL, 1992, Motility of fibronectin receptordeficient cells on fibronectin and vitronectin: collaborative interactions among integrins. J Cell Biol, 116, 477–87.

    Google Scholar 

  42. Pytela R, Pierschbacher MD, Argraves S, Suziki S and Ruoslahti E, 1987, Arginine-glycine-aspartic acid adhesion receptors. Meth Enzymol, 144, 475–89.

    Google Scholar 

  43. Pitti R, Hammonds RG, King K, et al. 1992, Laminin as a novel ligand for the αvβ3 integrin. J Cell Biochem, 16F, 152.

    Google Scholar 

  44. Lawler J, Weinstein R and Hynes RO, 1988, Cell attachment to thrombospondin: the role of Arg-Gly-Asp, calcium and integrin receptors. J Cell Biol, 107, 2351–61.

    Google Scholar 

  45. Zablocki JA, Miyano M, Garland RB, et al. 1993, Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Arg-guanidine of RGDX mimetics and the platelet GP IIb-IIIa receptor. J Med Chem, 36, 1811–19.

    Google Scholar 

  46. Ruoslahti E and Giancotti FG, 1989, Integrins and tumor cell dissemination. Cancer Cells, 1, 119–26.

    Google Scholar 

  47. Habermann-Felding B, Mueller BM, Romerdahl CA and Cheresh DA, 1992, Involvement of integrin αvgene expression in human melanoma tumorigenicity. J Clin Invest, 89, 2018–22.

    Google Scholar 

  48. Humphries MJ, Olden K and Yamada KM, 1986, A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science, 233, 467–9.

    Google Scholar 

  49. Soszka T, Knudsen KA, Beviglia L, Rossi C, Poggi A and Niewiarowski S, 1991, Inhibition of murine melanoma cell-matrix adhesion and experimental metastasis by albolabrin, an RGD-containing peptide isolated from the venom of Trimeresurus albolabris. Exp Cell Res, 196, 6–12.

    Google Scholar 

  50. Ugen KE, Mahalingam M, Klein PA and Kao KJ, 1988, Inhibition of tumor cell-induced platelet aggregation and experimental tumor metastasis by the synthetic Gly-Arg-Gly-Asp-Ser peptide. J Natl Cancer Inst, 80, 1461–6.

    Google Scholar 

  51. Isoai A, Ueno Y, Giga-Hama Y, Goto H and Kumagai H, 1992, A novel Arg-Gly-Asp containing peptide specific for platelet aggregation and its effect on tumor metastasis: a possible mechanism of RGD peptidemediated inhibition of tumor metastasis. Cancer Lett, 65, 259–64.

    Google Scholar 

  52. Hayman EG, Pierschbacher MD, Ohgren Y and Ruoslahti E, 1983, Serum spreading factor (vitronectin) is present at the cell surface and in tissues. Proc Natl Acad Sci USA, 80, 4003–7.

    Google Scholar 

  53. Simpson APF and Horton MA, 1989, Expression of the vitronectin receptor during embryonic development: an immunohistological study of the ontogeny of the osteoclast in rabbit. Br J Exp Pathol, 70, 257–65.

    Google Scholar 

  54. Nip J, Shibata H, Loskutoff DJ, Cheresh DA and Brodt P, 1992, Human melanoma cells derived from lymphatic metastases use integrin αvβ3 to adhere to lymph node vitronectin. J Clin Invest, 90, 1406–13.

    Google Scholar 

  55. Wayner EA, Orlando RA and Cheresh DA, 1991, Integrins αvβ3 and αvβ5 contribute to cell attachment to vitronectin but differentially distribute on the cell surface. J Cell Biol, 113, 919–29.

    Google Scholar 

  56. Leavesley DI, Ferguson GD, Wayner EA and Cheresh DA, 1992, Requirement of the integrin β3 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen. J Cell Biol, 117, 1101–7.

    Google Scholar 

  57. Choi ET, Engel LE, Callow AD, et al. 1994, Inhibition of neonatal hyperplasia by blocking αvβ3 integrin with a small peptide antagonist GpenGRGDSPCA. J Vasc Surg, 19, 125–34.

    Google Scholar 

  58. Languino LR and Ruoslahti E, 1992, An alternative form of the integrin b1 subunit with a variant cytoplasmic domain. J Biol Chem, 267, 7116–20.

    Google Scholar 

  59. Wei Y, Lukashev M, Simon DI, et al. 1996, Regulation of integrin function by the urokinase receptor. Science, 273, 1551–5.

    Google Scholar 

  60. Topol EJ and Plow EF, 1993, Clinical trials of platelet receptor inhibitors. Thromb Haemost, 70, 94–8.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cancer Research Center, Program on Cell Adhesion and the Extracellular Matrix, The Burnham Institute, La Jolla, CA, USA

    Nanette C. Wong, Emme C. K. Lin & Jeffrey W. Smith

  2. Department of Immunology, The Scripps Research Institute, La Jolla, CA, USA

    Barbara M. Mueller

  3. Department of Molecular, The Scripps Research Institute, La Jolla, CA, USA

    Carlos F. Barbas

  4. Department of Cell Biology, The Scripps Research Institute, La Jolla, CA, USA

    Pete Ruminski

  5. Monsanto/Searle St. Louis, MO, USA

    Vito Quaranta

Authors
  1. Nanette C. Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barbara M. Mueller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carlos F. Barbas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pete Ruminski
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vito Quaranta
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Emme C. K. Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jeffrey W. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wong, N.C., Mueller, B.M., Barbas, C.F. et al. αv Integrins mediate adhesion and migration of breast carcinoma cell lines. Clin Exp Metastasis 16, 50–61 (1998). https://doi.org/10.1023/A:1006512018609

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006512018609

Search

Navigation